Drawing for FUJIFILM

USPTO serial 87726002

FUJIFILM

Reviewed by CopyMark Law Group

Reg. 5524338Status 701Registered
Filing date
Status date
Registration date
Jul 24, 2018
Examiner
COLLOPY, DIANE PATRICIA
Law office
Historical data usage

What this means

Status 701 means the registration is active and the first Section 8 declaration of continued use was accepted. The next major deadline is the combined Section 8 and Section 9 filing at the 10-year anniversary. Calendar the 10-year Section 8 and 9 combined renewal.

Status 701: Status 701 means the registration is active and the first Section 8 declaration of continued use was accepted. The next major deadline is the combined Section 8 and Section 9 filing at the 10-year anniversary.

Need help with FUJIFILM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Suzanne M. Hengl

Suzanne M. Hengl Baker Botts L.L.P.30 Rockefeller Plaza44th FloorNew York, NY 10112-4498

Goods and services

ClassDescriptionStatusFirst use
001High purity solvents and chemicals for use in the electronics market; Aqueous acid blends for use in metal etching; Organic solvents for use in wafer surface pre-wetting prior to photoresist application; Organic chloride chemicals for use in furnace tube cleaning and silicon wafer oxidation and cleaning; [ Chemicals in the nature of infra-red absorbers for use in the manufacture of printing inks used for security printing applications for counterfeit and fraud detection; ] Unexposed x-ray film, not for medical use, used to inspect internal defects of objects such as aircraft engine parts, pipeline and valves without destruction; Unexposed photographic filmACTIVEDec 1, 2015
002Dyes and colorants for use in the manufacture of printing inks, namely, ink-jet printing inksACTIVEDec 31, 2006
007Gas separating apparatus, namely, gas separators; gas separating membranes as a part of gas separating apparatus; filters for gas separating apparatus; membrane modules for gas separating apparatus; Resin plates used as printing plates; printing plates; engraving machines for resin printing plates used for flexographic printing and replacement parts thereforACTIVENov 30, 2014
009Computer software program for the management and generation of patient specific image related information for use by healthcare providers for reviewing and communicating of medical history and medical images for the primary diagnosis, treatment and care of patients; [ Lenses for television and motion picture cameras; ] Film for pressure measurement, namely, film for use as a pressure indicator that changes color when pressure is applied and the color density changes according to the various pressure levels; film for pressure measurement for adjustment of pressure distribution and pressure balance purposes, namely, film for use as a pressure indicator that changes color when pressure is applied and the color density changes according to the various pressure levels; plastic sheets and plastic film for use as a pressure indicator that changes color when pressure is applied and the color density changes according to the various pressure levels; Computed radiography equipment, not for medical use, used to inspect internal defects of objects such as aircraft engine parts, pipeline and valves without destruction; Medical imaging software used for three-dimensional image visualization and analysis used by healthcare providers, namely, radiologists, cardiologists, surgeons, physician assistants, technologists and nurses for supporting diagnosis, treatment, planning and care of patients; Medical imaging software used for cardiology image management and reporting for use by healthcare providers for primary diagnosis, treatment, planning and care of patients; Downloadable medical imaging software for capturing, storing, managing, viewing, interpreting and sharing images and their associated objects, namely, reports, documents and notes, within a healthcare enterprise; Downloadable medical informatics software used to manage radiology operations and to connect outpatient workflow to enterprise imaging used by healthcare providers to support the imaging business and by patients for involvement in their own care, via a patient portal; Downloadable medical imaging software used by healthcare professionals accessed through the electronic health record, mobile or web platforms, to view images and reports for diagnosis, treatment, follow-up, and patient care coordination, enabling secure, easy-to-manage access to the complete patient imaging record throughout the healthcare enterprise [ ; Electronic storage devices in the nature of memory media for storing information for data processing installations; computer central processing unit for data processing; Video processors for use with medical and surgical apparatus and instruments ]ACTIVEDec 31, 2014
010Medical ultrasound apparatus; ultrasound diagnostic apparatus; Medical apparatus, namely, medical ultrasound device; medical diagnostic and screening ultrasound apparatus; Medical endoscopes; Medical devices for use in endoscopy procedures, namely, enteroscope, overtubes balloon and balloon-pump controller; Flexible Bronchoscope; [ Medical and surgical apparatus and instruments, namely, light sources for medical and surgical endoscopes; ] Laboratory equipment, namely, ultrasonic processors for use in connection with ultrasonic gastroscopes and ultrasound video bronchoscopeACTIVEJul 31, 2016
040Contract formulation for others in the field of biologic and advanced therapy products, namely, polypeptides, plasmid DNA, recombinant proteins, vaccines, monoclonal antibodies and enzymes; Contract manufacturing for others in the nature of mammalian, bacterial, insect and yeast cell expressions in the field of biologic and advanced therapy products, namely, polypeptides, plasmid DNA, recombinant proteins, vaccines, monoclonal antibodies and enzymes; Processing and manufacturing of vectors, cell cultures and recombinant proteins for use in biotechnology industries to the order and specification of others; manufacture, processing and production of recombinant proteins for use in the biotechnology industries to the order and specification of othersACTIVEDec 31, 2011
042Scientific, industrial and technical research, development and analysis services relating to the use of mammalian cell cultures and vectors in the field of biotechnology; process development, namely, development of processes for others for the use of mammalian cell cultures and vectors in the manufacture of biotechnology products; project studies for others relating to the use of mammalian cell cultures and vectors in the field of biotechnology; Research and development for others in the field of biologic products and advanced therapy products, namely, polypeptides, plasmid DNA, recombinant proteins, vaccines, monoclonal antibodies and enzymes; Analytical and stability testing services for others in the field of biologic products and advanced therapy products, namely, polypeptides, plasmid DNA, recombinant proteins, vaccines, monoclonal antibodies and enzymes; [ Electronic data back-up; conversion of data to electronic media; technical project management in the field of electronic data processing; electronic data storage and storage of data in computer databases; Recovery of computer data; ] providing online non-downloadable medical imaging software for capturing, storing, managing, viewing, interpreting and sharing images and their associated objects, namely, reports, documents and notes, within a healthcare enterprise; providing online non-downloadable medical informatics software used to manage radiology operations and to connect outpatient workflow to enterprise imaging used by healthcare providers to support the imaging business and by patients for involvement in their own care, via a patient portal; providing online non-downloadable medical imaging software used by healthcare professionals accessed through the electronic health record, mobile or web platforms, to view images and reports for diagnosis, treatment, follow-up, and patient care coordination, enabling secure, easy-to-manage access to the complete patient imaging record throughout the healthcare enterpriseACTIVEFeb 6, 2014

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 17, 2025NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Mar 17, 20258.OKREGISTERED - SEC. 8 (6-YR) ACCEPTEDThe USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline.
Mar 14, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 23, 2024ES8RTEAS SECTION 8 RECEIVED
Mar 8, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 8, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 8, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 8, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 8, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 24, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
May 31, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 31, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
May 31, 2022ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
May 31, 2022EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
May 31, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 31, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 31, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 24, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 8, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 8, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 18, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 29, 2018ALIEASSIGNED TO LIE
Mar 19, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Mar 17, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Mar 16, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 16, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 12, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 12, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 12, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 3, 2018DOCKASSIGNED TO EXAMINER
Jan 5, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 22, 2017NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance